Response to the Combination of Osimertinib, Dabrafenib, and Trametinib in Leptomeningitis From EGFR-Mutant NSCLC With Acquired BRAF V600E Mutation: A Case Report

by Orion Valet, Aurélie Swalduz, MD, Maxime Boussageon, MD, Adrien Buisson, Virginie Avrillon, MD, Bénédicte Mastroïanni, MD, Maurice Pérol, MD
Published 2021-06-01